Skip to main content
Top
Published in:

04-05-2024 | Cerebral Ischemic Stroke | Review

Delving Into the Significance of Brain’s Collateral Circulation in the Era of Revascularization Therapy

Authors: Marilena Mangiardi, MD, Sergio Soeren Rossi, MD, Adriano Bonura, MD, Gianmarco Iaccarino, MD, Michele Alessiani, MD, Sabrina Anticoli, MD, Gianluca De Rubeis, MD, Enrico Pampana, MD, Francesca Romana Pezzella, MD

Published in: Current Treatment Options in Neurology | Issue 7/2024

Login to get access

Abstract

Purpose of review

This narrative review summarized the major studies focusing on the association between revascularization therapies (intravenous thrombolysis and endovascular thrombectomy) and collateral circulation status in terms of outcome and safety. Our aim is to elucidate, drawing upon the latest scientific evidence, the pivotal role that collateral circulation plays in shaping the prognosis and potential therapeutic in patients with ischemic stroke.

Recent findings

The data currently available suggest that pre-treatment assessment of collateral circulation may be crucial, as a good collateral circulation status appears to be associated with better outcomes in terms of both early revascularization and long-term disability. There is limited literature about the assessment of collateral circulation prior to acute reperfusion therapy.

Summary

The role of the intracranial collateral circulation is gaining increasing attention in the field of ischemic stroke, both in terms of outcome prognosis and therapeutic interventions. These findings need to be confirmed by more structured randomized controlled trials (RCTs), but they suggest that investigating therapeutic strategies to maintain and support collateral circulation may represent the future of ischemic stroke therapy.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Delving Into the Significance of Brain’s Collateral Circulation in the Era of Revascularization Therapy
Authors
Marilena Mangiardi, MD
Sergio Soeren Rossi, MD
Adriano Bonura, MD
Gianmarco Iaccarino, MD
Michele Alessiani, MD
Sabrina Anticoli, MD
Gianluca De Rubeis, MD
Enrico Pampana, MD
Francesca Romana Pezzella, MD
Publication date
04-05-2024
Publisher
Springer US
Published in
Current Treatment Options in Neurology / Issue 7/2024
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-024-00794-7

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest